Recent knowledge in favor of remdesivir (GS-5734) as a therapeutic option for the COVID-19 infections

• Auteurs principaux: S. Saqrane (Auteur), M.A. El Mhammedi (Auteur), S. Lahrich (Auteur), F. Laghrib (Auteur), Y. El Bouabi (Auteur), A. Farahi (Auteur), M. Bakasse (Auteur)
• Format: Livre
• Publié: Elsevier, 2021-05-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

The management of SARS-CoV-2 has not yet been clearly determined and is based on potential therapies evaluated during the SARS-CoV and MERS-CoV outbreaks. An emerging potential therapeutic approach currently being evaluated in numerous clinical trials is the remdesivir agent, which acts on COVID-19...